Netflix shares face pressure as the streaming giant's 2026 revenue guidance signals a significant growth deceleration, even with its advertising business poised to double. Investor concerns are compounded by a potential multi-billion dollar acquisition.
The Walt Disney Company reported a 5% rise in fiscal first-quarter revenue to $26 billion, fueled by its theme parks and streaming services. However, operating profit fell 9% as challenges in its traditional TV business and rising costs offset gains.
Apple's fiscal first-quarter earnings shattered expectations with $143.8 billion in revenue, fueled by unprecedented demand for the iPhone 17 in Greater China. While services hit new highs, the company flags memory cost pressures and supply constraints for the coming quarter.
Twist Bioscience kicks off fiscal 2026 with robust growth, reporting a 17% year-over-year revenue increase to $103.7 million. The company credits its semiconductor-based DNA synthesis platform and surging demand from AI-enabled drug discovery programs as key drivers, while reiterating its path to adjusted EBITDA breakeven within the year.
Disney's theme parks and cruise lines delivered a historic $10 billion quarter, driving overall revenue past expectations. However, surging costs across its media and sports divisions squeezed profits as the entertainment giant nears a decision on its next chief executive.
Despite modest revenue growth and lack of profitability, Cognyte Software (NASDAQ: CGNT) has delivered a remarkable 133% return to shareholders over the past three years, highlighting a stark divergence between financial fundamentals and market optimism.
Hospitality tech provider Agilysys saw its stock price drop sharply post-earnings, even as Q4 revenue topped estimates. Higher development costs squeezed profits, though CEO highlighted strong subscription growth in key segments. Analysts are now scrutinizing the pace of major rollouts and efficiency gains.
Sanmina posted robust Q4 revenue, fueled by communications and AI infrastructure demand, yet shares fell as investors scrutinized softer margins and the integration of ZT Systems. Analysts on the earnings call zeroed in on the path to profitability and market diversification.
Harmony Biosciences CFO Sandip Kapadia has liquidated his entire direct stake in the company, a move that contrasts sharply with the firm's robust financial performance and bullish $1 billion revenue target for its flagship drug WAKIX by 2026. While the sales were pre-planned, the timing fuels debate on insider confidence versus corporate optimism.
Investors in Camellia Plc (LON:CAM) have faced a challenging half-decade, with shares falling 34% as the company grapples with shrinking revenues and an elusive path to profitability. While dividends have softened the blow, the stock continues to lag the broader market.
Carlisle Companies (NYSE: CSL) is scheduled to release its fourth-quarter earnings after market close on Tuesday, with analysts projecting steady revenue and adjusted EPS of $3.58. Investors are watching for signs of momentum in the building envelope sector.
The diversified solutions provider faces analyst expectations of a nearly 30% year-over-year revenue drop when it reports Tuesday afternoon, following a mixed track record against Wall Street estimates.
As BrightView Holdings prepares to report its fourth-quarter results, investors are watching closely to see if the commercial landscaping leader can halt a streak of revenue misses and navigate a challenging economic environment.
As The Hanover Insurance Group prepares to report its fourth-quarter results, investors are watching to see if the property and casualty insurer can meet revenue expectations in a volatile market. With peers like Travelers and Progressive already posting solid numbers, the pressure is on.
As Pfizer prepares to report its fourth-quarter results, investors are weighing the company's strategic pivot beyond its COVID-19 portfolio against a backdrop of expected revenue declines. The report may set the tone for the broader pharmaceutical sector.
Texas Instruments (TXN) reported a 70% year-over-year surge in data center orders, prompting the company to break out the segment separately. Management forecasts the first sequential revenue growth since 2008, citing improving industrial trends and AI-related infrastructure spending.
Vertiv Holdings Co launches 'Vertiv Next Predict,' an AI-driven managed service aimed at transforming data center maintenance through predictive analytics, signaling a strategic shift towards high-margin, recurring revenue streams.
Ontario's regulated online gambling sector capped a record-breaking year with a strong December performance, generating over $425 million in monthly revenue and pushing the annual total past the $4 billion mark, as the province's market continues to outpace growth seen in many U.S. states.
Altria Group (MO) posted stronger-than-expected Q4 revenue, driven by its core tobacco brands and oral nicotine products, but saw its shares fall as profit margins contracted sharply. The company is betting on a national rollout of its ON! Plus pouches and manufacturing upgrades to fuel its smoke-free future.
Dolby Laboratories surpassed Wall Street's Q4 revenue and profit forecasts, fueled by strong growth in automotive partnerships and streaming adoption. However, a year-over-year sales decline and contracting operating margins highlight the challenges of shifting product mix and restructuring costs.
